Global Central Nervous System Agents Sales Market Report 2016

December 2016 | 115 pages | ID: GA8053A7C37EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Central Nervous System Agents

Revenue, means the sales value of Central Nervous System Agents

This report studies sales (consumption) of Central Nervous System Agents in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

• Johnson & Johnson
• Pfizer
• Decartis
• Roche
• Sanofi
• Merck
• GSK
• Bayer
• Bristol-Myers Squibb
• AbbVie
• Eli Lilly
• AstraZeneca
• Takeda
• Actavis
• Astellas
• Teva
• Biogen
• Shire

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Central Nervous System Agents in these regions, from 2011 to 2021 (forecast), like

• United States
• China
• Europe
• Japan

Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Central Nervous System Agents in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

Global Central Nervous System Agents Sales Market Report 2016

1 CENTRAL NERVOUS SYSTEM AGENTS OVERVIEW

1.1 Product Overview and Scope of Central Nervous System Agents
1.2 Classification of Central Nervous System Agents
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Central Nervous System Agents
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 Central Nervous System Agents Market by Regions
  1.4.1 United States Status and Prospect (2011-2021)
  1.4.2 China Status and Prospect (2011-2021)
  1.4.3 Europe Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Central Nervous System Agents (2011-2021)
  1.5.1 Global Central Nervous System Agents Sales and Growth Rate (2011-2021)
  1.5.2 Global Central Nervous System Agents Revenue and Growth Rate (2011-2021)

2 GLOBAL CENTRAL NERVOUS SYSTEM AGENTS COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Global Central Nervous System Agents Market Competition by Manufacturers
  2.1.1 Global Central Nervous System Agents Sales and Market Share of Key Manufacturers (2011-2016)
  2.1.2 Global Central Nervous System Agents Revenue and Share by Manufacturers (2011-2016)
2.2 Global Central Nervous System Agents (Volume and Value) by Type
  2.2.1 Global Central Nervous System Agents Sales and Market Share by Type (2011-2016)
  2.2.2 Global Central Nervous System Agents Revenue and Market Share by Type (2011-2016)
2.3 Global Central Nervous System Agents (Volume and Value) by Regions
  2.3.1 Global Central Nervous System Agents Sales and Market Share by Regions (2011-2016)
  2.3.2 Global Central Nervous System Agents Revenue and Market Share by Regions (2011-2016)
2.4 Global Central Nervous System Agents (Volume) by Application

3 UNITED STATES CENTRAL NERVOUS SYSTEM AGENTS (VOLUME, VALUE AND SALES PRICE)

3.1 United States Central Nervous System Agents Sales and Value (2011-2016)
  3.1.1 United States Central Nervous System Agents Sales and Growth Rate (2011-2016)
  3.1.2 United States Central Nervous System Agents Revenue and Growth Rate (2011-2016)
  3.1.3 United States Central Nervous System Agents Sales Price Trend (2011-2016)
3.2 United States Central Nervous System Agents Sales and Market Share by Manufacturers
3.3 United States Central Nervous System Agents Sales and Market Share by Type
3.4 United States Central Nervous System Agents Sales and Market Share by Application

4 CHINA CENTRAL NERVOUS SYSTEM AGENTS (VOLUME, VALUE AND SALES PRICE)

4.1 China Central Nervous System Agents Sales and Value (2011-2016)
  4.1.1 China Central Nervous System Agents Sales and Growth Rate (2011-2016)
  4.1.2 China Central Nervous System Agents Revenue and Growth Rate (2011-2016)
  4.1.3 China Central Nervous System Agents Sales Price Trend (2011-2016)
4.2 China Central Nervous System Agents Sales and Market Share by Manufacturers
4.3 China Central Nervous System Agents Sales and Market Share by Type
4.4 China Central Nervous System Agents Sales and Market Share by Application

5 EUROPE CENTRAL NERVOUS SYSTEM AGENTS (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Central Nervous System Agents Sales and Value (2011-2016)
  5.1.1 Europe Central Nervous System Agents Sales and Growth Rate (2011-2016)
  5.1.2 Europe Central Nervous System Agents Revenue and Growth Rate (2011-2016)
  5.1.3 Europe Central Nervous System Agents Sales Price Trend (2011-2016)
5.2 Europe Central Nervous System Agents Sales and Market Share by Manufacturers
5.3 Europe Central Nervous System Agents Sales and Market Share by Type
5.4 Europe Central Nervous System Agents Sales and Market Share by Application

6 JAPAN CENTRAL NERVOUS SYSTEM AGENTS (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Central Nervous System Agents Sales and Value (2011-2016)
  6.1.1 Japan Central Nervous System Agents Sales and Growth Rate (2011-2016)
  6.1.2 Japan Central Nervous System Agents Revenue and Growth Rate (2011-2016)
  6.1.3 Japan Central Nervous System Agents Sales Price Trend (2011-2016)
6.2 Japan Central Nervous System Agents Sales and Market Share by Manufacturers
6.3 Japan Central Nervous System Agents Sales and Market Share by Type
6.4 Japan Central Nervous System Agents Sales and Market Share by Application

7 GLOBAL CENTRAL NERVOUS SYSTEM AGENTS MANUFACTURERS ANALYSIS

7.1 Johnson & Johnson
  7.1.1 Company Basic Information, Manufacturing Base and Competitors
  7.1.2 Central Nervous System Agents Product Type, Application and Specification
    7.1.2.1 Type I
    7.1.2.2 Type II
  7.1.3 Johnson & Johnson Central Nervous System Agents Sales, Revenue, Price and Gross Margin (2011-2016)
  7.1.4 Main Business/Business Overview
7.2 Pfizer
  7.2.1 Company Basic Information, Manufacturing Base and Competitors
  7.2.2 115 Product Type, Application and Specification
    7.2.2.1 Type I
    7.2.2.2 Type II
  7.2.3 Pfizer Central Nervous System Agents Sales, Revenue, Price and Gross Margin (2011-2016)
  7.2.4 Main Business/Business Overview
7.3 Decartis
  7.3.1 Company Basic Information, Manufacturing Base and Competitors
  7.3.2 130 Product Type, Application and Specification
    7.3.2.1 Type I
    7.3.2.2 Type II
  7.3.3 Decartis Central Nervous System Agents Sales, Revenue, Price and Gross Margin (2011-2016)
  7.3.4 Main Business/Business Overview
7.4 Roche
  7.4.1 Company Basic Information, Manufacturing Base and Competitors
  7.4.2 Dec Product Type, Application and Specification
    7.4.2.1 Type I
    7.4.2.2 Type II
  7.4.3 Roche Central Nervous System Agents Sales, Revenue, Price and Gross Margin (2011-2016)
  7.4.4 Main Business/Business Overview
7.5 Sanofi
  7.5.1 Company Basic Information, Manufacturing Base and Competitors
  7.5.2 Product Type, Application and Specification
    7.5.2.1 Type I
    7.5.2.2 Type II
  7.5.3 Sanofi Central Nervous System Agents Sales, Revenue, Price and Gross Margin (2011-2016)
  7.5.4 Main Business/Business Overview
7.6 Merck
  7.6.1 Company Basic Information, Manufacturing Base and Competitors
  7.6.2 Million USD Product Type, Application and Specification
    7.6.2.1 Type I
    7.6.2.2 Type II
  7.6.3 Merck Central Nervous System Agents Sales, Revenue, Price and Gross Margin (2011-2016)
  7.6.4 Main Business/Business Overview
7.7 GSK
  7.7.1 Company Basic Information, Manufacturing Base and Competitors
  7.7.2 Pharma & Healthcare Product Type, Application and Specification
    7.7.2.1 Type I
    7.7.2.2 Type II
  7.7.3 GSK Central Nervous System Agents Sales, Revenue, Price and Gross Margin (2011-2016)
  7.7.4 Main Business/Business Overview
7.8 Bayer
  7.8.1 Company Basic Information, Manufacturing Base and Competitors
  7.8.2 Product Type, Application and Specification
    7.8.2.1 Type I
    7.8.2.2 Type II
  7.8.3 Bayer Central Nervous System Agents Sales, Revenue, Price and Gross Margin (2011-2016)
  7.8.4 Main Business/Business Overview
7.9 Bristol-Myers Squibb
  7.9.1 Company Basic Information, Manufacturing Base and Competitors
  7.9.2 Product Type, Application and Specification
    7.9.2.1 Type I
    7.9.2.2 Type II
  7.9.3 Bristol-Myers Squibb Central Nervous System Agents Sales, Revenue, Price and Gross Margin (2011-2016)
  7.9.4 Main Business/Business Overview
7.10 AbbVie
  7.10.1 Company Basic Information, Manufacturing Base and Competitors
  7.10.2 Product Type, Application and Specification
    7.10.2.1 Type I
    7.10.2.2 Type II
  7.10.3 AbbVie Central Nervous System Agents Sales, Revenue, Price and Gross Margin (2011-2016)
  7.10.4 Main Business/Business Overview
7.11 Eli Lilly
7.12 AstraZeneca
7.13 Takeda
7.14 Actavis
7.15 Astellas
7.16 Teva
7.17 Biogen
7.18 Shire

8 CENTRAL NERVOUS SYSTEM AGENTS MAUFACTURING COST ANALYSIS

8.1 Central Nervous System Agents Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Process Analysis of Central Nervous System Agents

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Central Nervous System Agents Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Central Nervous System Agents Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL CENTRAL NERVOUS SYSTEM AGENTS MARKET FORECAST (2016-2021)

12.1 Global Central Nervous System Agents Sales, Revenue Forecast (2016-2021)
12.2 Global Central Nervous System Agents Sales Forecast by Regions (2016-2021)
12.3 Global Central Nervous System Agents Sales Forecast by Type (2016-2021)
12.4 Global Central Nervous System Agents Sales Forecast by Application (2016-2021)

13 APPENDIX

Disclosure Section
Research Methodology
Data Source
China Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Central Nervous System Agents
Table Classification of Central Nervous System Agents
Figure Global Sales Market Share of Central Nervous System Agents by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Applications of Central Nervous System Agents
Figure Global Sales Market Share of Central Nervous System Agents by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure United States Central Nervous System Agents Revenue and Growth Rate (2011-2021)
Figure China Central Nervous System Agents Revenue and Growth Rate (2011-2021)
Figure Europe Central Nervous System Agents Revenue and Growth Rate (2011-2021)
Figure Japan Central Nervous System Agents Revenue and Growth Rate (2011-2021)
Figure Global Central Nervous System Agents Sales and Growth Rate (2011-2021)
Figure Global Central Nervous System Agents Revenue and Growth Rate (2011-2021)
Table Global Central Nervous System Agents Sales of Key Manufacturers (2011-2016)
Table Global Central Nervous System Agents Sales Share by Manufacturers (2011-2016)
Figure 2015 Central Nervous System Agents Sales Share by Manufacturers
Figure 2016 Central Nervous System Agents Sales Share by Manufacturers
Table Global Central Nervous System Agents Revenue by Manufacturers (2011-2016)
Table Global Central Nervous System Agents Revenue Share by Manufacturers (2011-2016)
Table 2015 Global Central Nervous System Agents Revenue Share by Manufacturers
Table 2016 Global Central Nervous System Agents Revenue Share by Manufacturers
Table Global Central Nervous System Agents Sales and Market Share by Type (2011-2016)
Table Global Central Nervous System Agents Sales Share by Type (2011-2016)
Figure Sales Market Share of Central Nervous System Agents by Type (2011-2016)
Figure Global Central Nervous System Agents Sales Growth Rate by Type (2011-2016)
Table Global Central Nervous System Agents Revenue and Market Share by Type (2011-2016)
Table Global Central Nervous System Agents Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Central Nervous System Agents by Type (2011-2016)
Figure Global Central Nervous System Agents Revenue Growth Rate by Type (2011-2016)
Table Global Central Nervous System Agents Sales and Market Share by Regions (2011-2016)
Table Global Central Nervous System Agents Sales Share by Regions (2011-2016)
Figure Sales Market Share of Central Nervous System Agents by Regions (2011-2016)
Figure Global Central Nervous System Agents Sales Growth Rate by Regions (2011-2016)
Table Global Central Nervous System Agents Revenue and Market Share by Regions (2011-2016)
Table Global Central Nervous System Agents Revenue Share by Regions (2011-2016)
Figure Revenue Market Share of Central Nervous System Agents by Regions (2011-2016)
Figure Global Central Nervous System Agents Revenue Growth Rate by Regions (2011-2016)
Table Global Central Nervous System Agents Sales and Market Share by Application (2011-2016)
Table Global Central Nervous System Agents Sales Share by Application (2011-2016)
Figure Sales Market Share of Central Nervous System Agents by Application (2011-2016)
Figure Global Central Nervous System Agents Sales Growth Rate by Application (2011-2016)
Figure United States Central Nervous System Agents Sales and Growth Rate (2011-2016)
Figure United States Central Nervous System Agents Revenue and Growth Rate (2011-2016)
Figure United States Central Nervous System Agents Sales Price Trend (2011-2016)
Table United States Central Nervous System Agents Sales by Manufacturers (2011-2016)
Table United States Central Nervous System Agents Market Share by Manufacturers (2011-2016)
Table United States Central Nervous System Agents Sales by Type (2011-2016)
Table United States Central Nervous System Agents Market Share by Type (2011-2016)
Table United States Central Nervous System Agents Sales by Application (2011-2016)
Table United States Central Nervous System Agents Market Share by Application (2011-2016)
Figure China Central Nervous System Agents Sales and Growth Rate (2011-2016)
Figure China Central Nervous System Agents Revenue and Growth Rate (2011-2016)
Figure China Central Nervous System Agents Sales Price Trend (2011-2016)
Table China Central Nervous System Agents Sales by Manufacturers (2011-2016)
Table China Central Nervous System Agents Market Share by Manufacturers (2011-2016)
Table China Central Nervous System Agents Sales by Type (2011-2016)
Table China Central Nervous System Agents Market Share by Type (2011-2016)
Table China Central Nervous System Agents Sales by Application (2011-2016)
Table China Central Nervous System Agents Market Share by Application (2011-2016)
Figure Europe Central Nervous System Agents Sales and Growth Rate (2011-2016)
Figure Europe Central Nervous System Agents Revenue and Growth Rate (2011-2016)
Figure Europe Central Nervous System Agents Sales Price Trend (2011-2016)
Table Europe Central Nervous System Agents Sales by Manufacturers (2011-2016)
Table Europe Central Nervous System Agents Market Share by Manufacturers (2011-2016)
Table Europe Central Nervous System Agents Sales by Type (2011-2016)
Table Europe Central Nervous System Agents Market Share by Type (2011-2016)
Table Europe Central Nervous System Agents Sales by Application (2011-2016)
Table Europe Central Nervous System Agents Market Share by Application (2011-2016)
Figure Japan Central Nervous System Agents Sales and Growth Rate (2011-2016)
Figure Japan Central Nervous System Agents Revenue and Growth Rate (2011-2016)
Figure Japan Central Nervous System Agents Sales Price Trend (2011-2016)
Table Japan Central Nervous System Agents Sales by Manufacturers (2011-2016)
Table Japan Central Nervous System Agents Market Share by Manufacturers (2011-2016)
Table Japan Central Nervous System Agents Sales by Type (2011-2016)
Table Japan Central Nervous System Agents Market Share by Type (2011-2016)
Table Japan Central Nervous System Agents Sales by Application (2011-2016)
Table Japan Central Nervous System Agents Market Share by Application (2011-2016)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Central Nervous System Agents Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Johnson & Johnson Central Nervous System Agents Global Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Central Nervous System Agents Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Central Nervous System Agents Global Market Share (2011-2016)
Table Decartis Basic Information List
Table Decartis Central Nervous System Agents Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Decartis Central Nervous System Agents Global Market Share (2011-2016)
Table Roche Basic Information List
Table Roche Central Nervous System Agents Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Roche Central Nervous System Agents Global Market Share (2011-2016)
Table Sanofi Basic Information List
Table Sanofi Central Nervous System Agents Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Sanofi Central Nervous System Agents Global Market Share (2011-2016)
Table Merck Basic Information List
Table Merck Central Nervous System Agents Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Merck Central Nervous System Agents Global Market Share (2011-2016)
Table GSK Basic Information List
Table GSK Central Nervous System Agents Sales, Revenue, Price and Gross Margin (2011-2016)
Figure GSK Central Nervous System Agents Global Market Share (2011-2016)
Table Bayer Basic Information List
Table Bayer Central Nervous System Agents Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Bayer Central Nervous System Agents Global Market Share (2011-2016)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Central Nervous System Agents Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Bristol-Myers Squibb Central Nervous System Agents Global Market Share (2011-2016)
Table AbbVie Basic Information List
Table AbbVie Central Nervous System Agents Sales, Revenue, Price and Gross Margin (2011-2016)
Figure AbbVie Central Nervous System Agents Global Market Share (2011-2016)
Table Eli Lilly Basic Information List
Table Eli Lilly Central Nervous System Agents Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Eli Lilly Central Nervous System Agents Global Market Share (2011-2016)
Table AstraZeneca Basic Information List
Table AstraZeneca Central Nervous System Agents Sales, Revenue, Price and Gross Margin (2011-2016)
Figure AstraZeneca Central Nervous System Agents Global Market Share (2011-2016)
Table Takeda Basic Information List
Table Takeda Central Nervous System Agents Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Takeda Central Nervous System Agents Global Market Share (2011-2016)
Table Actavis Basic Information List
Table Actavis Central Nervous System Agents Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Actavis Central Nervous System Agents Global Market Share (2011-2016)
Table Astellas Basic Information List
Table Astellas Central Nervous System Agents Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Astellas Central Nervous System Agents Global Market Share (2011-2016)
Table Teva Basic Information List
Table Teva Central Nervous System Agents Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Teva Central Nervous System Agents Global Market Share (2011-2016)
Table Biogen Basic Information List
Table Biogen Central Nervous System Agents Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Biogen Central Nervous System Agents Global Market Share (2011-2016)
Table Shire Basic Information List
Table Shire Central Nervous System Agents Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Shire Central Nervous System Agents Global Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Central Nervous System Agents
Figure Manufacturing Process Analysis of Central Nervous System Agents
Figure Central Nervous System Agents Industrial Chain Analysis
Table Raw Materials Sources of Central Nervous System Agents Major Manufacturers in 2015
Table Major Buyers of Central Nervous System Agents
Table Distributors/Traders List
Figure Global Central Nervous System Agents Sales and Growth Rate Forecast (2016-2021)
Figure Global Central Nervous System Agents Revenue and Growth Rate Forecast (2016-2021)
Table Global Central Nervous System Agents Sales Forecast by Regions (2016-2021)
Table Global Central Nervous System Agents Sales Forecast by Type (2016-2021)
Table Global Central Nervous System Agents Sales Forecast by Application (2016-2021)